SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-14-009164
Filing Date
2014-12-29
Accepted
2014-12-29 17:08:49
Documents
40

Document Format Files

Seq Description Document Type Size
1 ea141218002.htm F-1 8562437
2 COMPANIES LAW, 5759 1999 ff12014ex3i_biondvax.htm EX-3.1 369537
3 drs2014ex4iiii_biondvax.htm EX-4.3 869
4 LICENCE AGREEMENT drs2014ex10i_biondvax.htm EX-10.1 439735
5 EXECUTION COPY drs2014ex10ii_biondvax.htm EX-10.2 439805
6 CONSORTIUM AGREEMENT drs2014ex10iii_biondvax.htm EX-10.3 198733
7 ISRAELI SHARE OPTION PLAN drs2014ex10iv_biondvax.htm EX-10.4 184974
8 MANAGEMENT SERVICES AGREEMENT drs2014ex10v_biondvax.htm EX-10.5 101423
9 EMPLOYMENT AGREEMENT ff12014ex10vi_biondvax.htm EX-10.6 142137
10 ff12014ex10vii_biondvax.htm EX-10.7 29467
11 BIONDVAX PHARMACEUTICALS LTD . ff12014ex10viii_biondvax.htm EX-10.8 6855
12 BIONDVAX drs2014ex10ix_biondvax.htm EX-10.9 52560
13 SUMMARY OF THE LEASE AGREEMENT drs2014ex10x_biondvax.htm EX-10.10 75206
14 ADDENDUM TO EMPLOYMENT AGREEMENT DATED APRIL 1, 2012, BETWEEN BIONDVAX PHARMACEU ff12014ex10xi_biondvax.htm EX-10.11 25351
15 ADDENDUM TO SERVICE AGREEMENT DATED AUGUST 31, 2014, BETWEEN BIONDVAX PHARMACEUT ff12014ex10xii_biondvax.htm EX-10.12 90669
16 EMPLOYMENT AGREEMENT DATED AUGUST 31, 2014, BETWEEN BIONDVAX PHARMACEUTICALS LTD ff12014ex10xiii_biondvax.htm EX-10.13 84691
17 LETTER OF APPOINTMENT OF PROF. ETHAN RUBINSTEIN TO BIONDVAX PHARMACEUTICALS LTD. ff12014ex10xiv_biondvax.htm EX-10.14 25479
18 LETTER OF APPOINTMENT OF PROF. MICHEL REVEL TO BIONDVAX PHARMACEUTICALS LTD.'S S ff12014ex10xv_biondvax.htm EX-10.15 18264
19 LETTER OF APPOINTMENT OF PROF. RUTH ARNON TO BIONDVAX PHARMACEUTICALS LTD.'S SCI ff12014ex10xvi_biondvax.htm EX-10.16 70795
20 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ff12014ex23i_biondvax.htm EX-23.1 2408
21 GRAPHIC img031_v1.jpg GRAPHIC 100025
22 GRAPHIC ex10itc1.jpg GRAPHIC 121513
23 GRAPHIC ex10itc2.jpg GRAPHIC 180248
24 GRAPHIC yeda.jpg GRAPHIC 10391
25 GRAPHIC img032_v1.jpg GRAPHIC 934
26 GRAPHIC img033_v1.jpg GRAPHIC 1131
27 GRAPHIC img034_v1.jpg GRAPHIC 772
28 GRAPHIC img035_v1.jpg GRAPHIC 754
29 GRAPHIC img036_v1.jpg GRAPHIC 778
30 GRAPHIC img037_v1.jpg GRAPHIC 730
31 GRAPHIC img038_v1.jpg GRAPHIC 797
32 GRAPHIC img003_v1.jpg GRAPHIC 4218
33 GRAPHIC img1.jpg GRAPHIC 6109
34 GRAPHIC image001.jpg GRAPHIC 15590
35 GRAPHIC image002.jpg GRAPHIC 29898
36 GRAPHIC image003.jpg GRAPHIC 29900
37 GRAPHIC image004.jpg GRAPHIC 24536
38 GRAPHIC image005.jpg GRAPHIC 17163
39 GRAPHIC image006.jpg GRAPHIC 7217
40 GRAPHIC image007.jpg GRAPHIC 24557
  Complete submission text file 0001213900-14-009164.txt   11720501
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: F-1 | Act: 33 | File No.: 333-201283 | Film No.: 141313416
SIC: 2836 Biological Products, (No Diagnostic Substances)